Search

Sodium Channel Inhibitor Compounds EP3494105A2

The European Patent Office granted patent EP3494105A2 to the Human Biomolecular Research Institute on April 15, 2026, covering compounds as inhibitors of sodium channels. The patent designates multiple European states and lists inventors CASHMAN, John, R., RYAN, Daniel, J., and OKOLOTOWICZ, Karl. IPC classifications span therapeutic compound classes including A61P9/06 (cardiovascular) and A61P25/08 (anti-epileptic), indicating potential pharmaceutical applications for sodium channel modulation.